当前位置:首页 - 行情中心 - 康众医疗(688607) - 财务分析 - 利润表

康众医疗

(688607)

  

流通市值:16.44亿  总市值:16.44亿
流通股本:8812.90万   总股本:8812.90万

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入58,438,952.04298,100,384.74195,501,808.26128,884,465.05
营业收入58,438,952.04298,100,384.74195,501,808.26128,884,465.05
二、营业总成本59,877,941.01282,855,089.52187,959,296.34124,636,325.65
营业成本37,465,870.05180,262,672.32111,618,458.7576,063,051.04
税金及附加332,700.051,868,850.971,541,365.321,314,216.96
销售费用6,758,839.6431,405,186.425,087,036.1915,692,268.64
管理费用9,095,008.8326,779,469.4518,711,493.3111,823,463.24
研发费用6,792,353.0243,724,174.9430,522,635.5120,970,442.56
财务费用-566,830.58-1,185,264.56478,307.26-1,227,116.79
其中:利息费用292,031.56752,045.28754,092.88302,182.83
其中:利息收入155,123.241,071,859.32438,095.71655,557.69
加:公允价值变动收益-48,560.81-1,146,507.39-1,425,050.19-711,236.49
加:投资收益-654,012.066,940,131.057,899,779.414,829,724.7
资产处置收益5,515.14-3,175.66--
资产减值损失(新)18,900.4-5,329,912.79-1,178,675.91-479,459.04
信用减值损失(新)-403,129.28-1,314,722.41-918,152.39-1,227,486.96
其他收益569,191.793,185,095.442,185,374.031,401,672.16
营业利润平衡项目0000
四、营业利润-1,951,083.7917,576,203.4614,105,786.878,061,353.77
加:营业外收入28,128.3197,334.49314,144.7585,001.76
减:营业外支出-88,110.9736,812.9834,484.47
利润总额平衡项目0000
五、利润总额-1,922,955.4917,685,426.9814,383,118.648,111,871.06
减:所得税费用1,390,122.339,718.951,791,208.95803,753.27
六、净利润-3,313,077.8217,675,708.0312,591,909.697,308,117.79
持续经营净利润-3,313,077.8217,675,708.0312,591,909.697,308,117.79
归属于母公司股东的净利润-3,281,29217,652,732.4312,586,307.987,317,939.67
少数股东损益-31,785.8222,975.65,601.71-9,821.88
(一)基本每股收益-0.040.20.140.08
(二)稀释每股收益-0.040.20.140.08
八、其他综合收益39,257.05929,755.71-3,301,607.96-368,412.3
归属于母公司股东的其他综合收益41,175.43929,293.73-3,300,787.87-368,221.19
九、综合收益总额-3,269,984.0118,605,463.749,291,941.916,939,705.49
归属于母公司股东的综合收益总额-3,240,116.5718,582,026.169,285,520.116,949,718.48
归属于少数股东的综合收益总额-29,867.4423,437.586,421.8-10,012.99
公告日期2025-04-262025-04-262024-10-262024-08-24
审计意见(境内)标准无保留意见
TOP↑